EPO could be regulated by HIF-1 and promote osteogenesis and accelerate bone repair

References

• Bogdanovski DA, DiFazio LT, Bogdanovski AK, et al. Hypoxia-inducible-factor-1 in trauma and critical care. J Crit Care. 2017;42:207–212.
   PubMed Web of Science ®Google Scholar
• Cheng YL, Park JS, Manzanero S, et al. Evidence that collaboration between HIF-1alpha and Notch-1 promotes neuronal cell death in ischemic stroke. Neurobiol Dis. 2014;62:286–295.
   PubMed Web of Science ®Google Scholar
• Gomez-Cerezo JF, Pagan-Munoz B, Lopez-Rodriguez M, et al. The role of endothelial progenitor cells and statins in endothelial function: a review. Cardiovasc Hematol Agents Med Chem. 2007;5(4):265–272.
   PubMedGoogle Scholar
• Moubarik C, Guillet B, Youssef B, et al. Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke. Stem Cell Rev and Rep. 2011;7(1):208–220.
   PubMed Web of Science ®Google Scholar
• Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis?. J Mol Cell Cardiol. 2011;50(2):266–272.
   PubMed Web of Science ®Google Scholar
• Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335–348.
   PubMed Web of Science ®Google Scholar
• Rosell A, Arai K, Lok J, et al. Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. J Cereb Blood Flow Metab. 2009;29(5):933–943.
   PubMed Web of Science ®Google Scholar
• Song Y, Li X, Wang D, et al. Transcription factor Kruppel-like factor 2 plays a vital role in endothelial colony forming cells differentiation. Cardiovasc Res. 2013;99(3):514–524.
   PubMed Web of Science ®Google Scholar
• Li X, Han Y, Pang W, et al. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28(10):1789–1795.
   PubMed Web of Science ®Google Scholar
• Balaji S, Han N, Moles C, et al. Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds. Surgery. 2015;158(3):846–856.
   PubMed Web of Science ®Google Scholar
• Bahlmann FH, DeGroot K, Duckert T, et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int. 2003;64(5):1648–1652.
   PubMed Web of Science ®Google Scholar
• Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8(8):495–505.
   PubMed Web of Science ®Google Scholar
• Ehrenreich H, Weissenborn K, Prange H, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40(12):e647–656.
   PubMed Web of Science ®Google Scholar
• Hankenson KD, Dishowitz M, Gray C, et al. Angiogenesis in bone regeneration. Injury. 2011;42(6):556–561.
   PubMed Web of Science ®Google Scholar
• Holstein JH, Orth M, Scheuer C, et al. Erythropoietin stimulates bone formation, cell proliferation, and angiogenesis in a femoral segmental defect model in mice. Bone. 2011;49(5):1037–1045.
   PubMed Web of Science ®Google Scholar
• Fiordaliso F, Chimenti S, Staszewsky L, et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci USA. 2005;102(6):2046–2051.
   PubMed Web of Science ®Google Scholar
• Schmeding M, Hunold G, Ariyakhagorn V, et al. Erythropoietin reduces ischemia-reperfusion injury after liver transplantation in rats. Transpl Int. 2009;22(7):738–746.
   PubMed Web of Science ®Google Scholar
• Xu T, Jin H, Lao Y, et al. Administration of erythropoietin prevents bone loss in osteonecrosis of the femoral head in mice. Mol Med Rep. 2017;16(6):8755–8762.
   PubMed Web of Science ®Google Scholar
• Kim J, Jung Y, Sun H, et al. Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem. 2012;113(1):220–228.
   PubMed Web of Science ®Google Scholar
• Chen J, Gu Z, Wu M, et al. C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1alpha via CD64/PI3k/Akt and MAPK/ERK signaling pathways. Stem Cell Res Ther. 2016;7(1):114.
   PubMedGoogle Scholar
• Mahfouz N, Tahtouh R, Alaaeddine N, et al. Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1alpha and VEGF receptors. PLoS One. 2017;12(6):e0179202.
   PubMed Web of Science ®Google Scholar
• Andersen TL, Sondergaard TE, Skorzynska KE, et al. A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol. 2009;174(1):239–247.
   PubMed Web of Science ®Google Scholar
• Zou D, Han W, You S, et al. In vitro study of enhanced osteogenesis induced by HIF-1alpha-transduced bone marrow stem cells. Cell Prolif. 2011;44(3):234–243.
   PubMed Web of Science ®Google Scholar
• Mao Z, Shi H, Guo R, et al. Enhanced angiogenesis of porous collagen scaffolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor. Acta Biomater. 2009;5(8):2983–2994.
   PubMed Web of Science ®Google Scholar
• Yu H, VandeVord PJ, Mao L, et al. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials. 2009;30(4):508–517.
   PubMed Web of Science ®Google Scholar
• Yu Y, Ren S, Yao Y, et al. Electrospun fibrous scaffolds with iron-doped hydroxyapatite exhibit osteogenic potential with static magnetic field exposure. J Biomed Nanotechnol. 2017;13(7):835–847.
   Web of Science ®Google Scholar
• Spicer PP, Kretlow JD, Young S, et al. Evaluation of bone regeneration using the rat critical size calvarial defect. Nat Protoc. 2012;7(10):1918–1929.
   PubMed Web of Science ®Google Scholar
• Eggold JT, Rankin EB. Erythropoiesis, EPO, macrophages, and bone. Bone. 2018;119:36–41
   PubMed Web of Science ®Google Scholar
• Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood. 1999;94(6):1864–1877.
   PubMed Web of Science ®Google Scholar
• Rankin EB, Wu C, Khatri R, et al. The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell. 2012;149(1):63–74.
   PubMed Web of Science ®Google Scholar
• Wang D, Song Y, Zhang J, et al. AMPK-KLF2 signaling pathway mediates the proangiogenic effect of erythropoietin in endothelial colony-forming cells. Am J Physiol Cell Physiol. 2017;313(6):C674–C685.
   PubMed Web of Science ®Google Scholar
• Rissanen TT, Vajanto I, Hiltunen MO, et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol. 2002;160(4):1393–1403.
   PubMed Web of Science ®Google Scholar
• Wang J, Fu X, Jiang C, et al. Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia. Behav Brain Res. 2014;265:171–180.
   PubMed Web of Science ®Google Scholar
• Weinstein RS, Wan C, Liu Q, et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell. 2010;9(2):147–161.
   PubMed Web of Science ®Google Scholar
• Wan L, Zhang F, He Q, et al. EPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesis. PLoS One. 2014;9(7):e102010.
   PubMed Web of Science ®Google Scholar
• Shiozawa Y, Jung Y, Ziegler AM, et al. Erythropoietin couples hematopoiesis with bone formation. PLoS One. 2010;5(5):e10853.
   PubMed Web of Science ®Google Scholar
• Li C, Shi C, Kim J, et al. Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling. J Dent Res. 2015;94(3):455–463.
   PubMed Web of Science ®Google Scholar
• Patel JJ, Modes JE, Flanagan CL, et al. Dual delivery of EPO and BMP2 from a novel modular poly-varepsilon-caprolactone construct to increase the bone formation in prefabricated bone flaps. Tissue Eng Part C Methods. 2015;21(9):889–897.
   PubMed Web of Science ®Google Scholar
• Lu J, Jiang L, Zhu H, et al. Hypoxia-inducible factor-1alpha and erythropoietin expression in the hippocampus of neonatal rats following hypoxia-ischemia. J Nanosci Nanotechnol. 2014;14(8):5614–5619.
   PubMed Web of Science ®Google Scholar
• Rayner BS, Duong TT, Myers SJ, et al. Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J Neurochem. 2006;97(1):211–221.
   PubMed Web of Science ®Google Scholar
• Cubranic A, Redzovic A, Dobrila-Dintinjana R, et al. Mystery story about Erythropoietin (Epo) and Erythropoietin receptor (Epor) are disguised?. Hepatogastroenterology. 2015;62(139):585–589.
   PubMedGoogle Scholar